Document is current
Any future updates will be listed below
-
Authors
Hautakangas, Heidi https://orcid.org/0000-0002-5585-6856
Winsvold, Bendik S. https://orcid.org/0000-0003-4171-8919
Ruotsalainen, Sanni E. https://orcid.org/0000-0002-1631-4069
Bjornsdottir, Gyda
Harder, Aster V. E. https://orcid.org/0000-0002-5477-7232
Kogelman, Lisette J. A. https://orcid.org/0000-0001-9782-7810
Thomas, Laurent F. https://orcid.org/0000-0003-0548-2486
Noordam, Raymond https://orcid.org/0000-0001-7801-809X
Benner, Christian
Gormley, Padhraig
Artto, Ville
Banasik, Karina https://orcid.org/0000-0003-2489-2499
Bjornsdottir, Anna
Boomsma, Dorret I. https://orcid.org/0000-0002-7099-7972
Brumpton, Ben M. https://orcid.org/0000-0002-3058-1059
Burgdorf, Kristoffer Sølvsten
Buring, Julie E.
Chalmer, Mona Ameri https://orcid.org/0000-0003-4609-1895
de Boer, Irene https://orcid.org/0000-0002-7261-762X
Dichgans, Martin https://orcid.org/0000-0002-0654-387X
Erikstrup, Christian https://orcid.org/0000-0001-6551-6647
Färkkilä, Markus
Garbrielsen, Maiken Elvestad
Ghanbari, Mohsen https://orcid.org/0000-0002-9476-7143
Hagen, Knut
Häppölä, Paavo
Hottenga, Jouke-Jan https://orcid.org/0000-0002-5668-2368
Hrafnsdottir, Maria G.
Hveem, Kristian
Johnsen, Marianne Bakke
Kähönen, Mika
Kristoffersen, Espen S. https://orcid.org/0000-0002-8999-5424
Kurth, Tobias https://orcid.org/0000-0001-7169-2620
Lehtimäki, Terho https://orcid.org/0000-0002-2555-4427
Lighart, Lannie https://orcid.org/0000-0002-6570-3319
Magnusson, Sigurdur H. https://orcid.org/0000-0001-6669-3071
Malik, Rainer
Pedersen, Ole Birger https://orcid.org/0000-0003-2312-5976
Pelzer, Nadine https://orcid.org/0000-0003-1763-5443
Penninx, Brenda W. J. H.
Ran, Caroline https://orcid.org/0000-0003-0239-9871
Ridker, Paul M.
Rosendaal, Frits R.
Sigurdardottir, Gudrun R.
Skogholt, Anne Heidi https://orcid.org/0000-0001-7466-0405
Sveinsson, Olafur A.
Thorgeirsson, Thorgeir E.
Ullum, Henrik
Vijfhuizen, Lisanne S.
Widén, Elisabeth
van Dijk, Ko Willems https://orcid.org/0000-0002-2172-7394
,
de Boer, Irene
van den Maagdenberg, Arn M. J. M.
,
,
Aromaa, Arpo
Belin, Andrea Carmine https://orcid.org/0000-0001-6668-3172
Freilinger, Tobias
Ikram, M. Arfan https://orcid.org/0000-0003-0372-8585
Järvelin, Marjo-Riitta https://orcid.org/0000-0002-2149-0630
Raitakari, Olli T.
Terwindt, Gisela M.
Kallela, Mikko
Wessman, Maija
Olesen, Jes https://orcid.org/0000-0002-6712-2702
Chasman, Daniel I. https://orcid.org/0000-0003-3357-0862
Nyholt, Dale R. https://orcid.org/0000-0001-7159-3040
Stefánsson, Hreinn https://orcid.org/0000-0002-9331-6666
Stefansson, Kari https://orcid.org/0000-0003-1676-864X
van den Maagdenberg, Arn M. J. M.
Hansen, Thomas Folkmann https://orcid.org/0000-0001-6703-7762
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Zwart, John-Anker https://orcid.org/0000-0001-5721-0154
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Pirinen, Matti https://orcid.org/0000-0002-1664-1350
- License Information
-
More Information
Article History
Received: 12 January 2021
Accepted: 22 November 2021
First Online: 3 February 2022
Competing interests
: G.B., T.E.T., S.H.M., H.S. and K.S. are employees of deCODE genetics/Amgen. P.G. is a current employee and stockholder of GlaxoSmithKline but work was conducted while employed by Massachusetts General Hospital, Boston, MA, USA. T.F. reports possible competing interest for Electrocore (participation in clinical studies), Novartis (speakers’ honoraria, participation in advisory boards, participation in clinical studies), Teva (speakers’ honoraria, participation in advisory boards), Lilly (speakers’ honoraria, participation in clinical studies), and Bayer (speakers’ honoraria). M. Kallela has served on Advisory Boards for MSD and Allergan; has received funding for travel and/or speaker honoraria from MSD, Allergan, Teva, Novartis and Genzyme; has received compensation for producing educational material from Teva and Allergan; has received research support from Helsinki University Central Hospital; and holds stock/stock options and/or has received Board of Directors compensation from Helsinki Headache Center. T.K. reports having received honoraria from Eli Lilly, Newsenselab and Total for providing methodological advice and from the BMJ for editorial services. A.P. is the Scientific Director of the public–private partnership project FinnGen that has 12 industry partners that provide funding for the FinnGen project. V.A. has served on advisory board for Allergan, Lundbeck, Teva and Lilly. G.M.T. reports consultancy support from Novartis, Allergan, Lilly and Teva, and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte. Other authors report no competing interests.
